Ethos Technologies (LIFE) Capital Expenditures (2025 - 2026)
Ethos Technologies (LIFE) posted Capital Expenditures of $325000.0 for Q2 2026, down 7.93% on a QoQ basis from $353000.0 in Q1 2026, and up 8.33% year-over-year from $300000.0 in Q2 2025.
Analysis
Ethos Technologies (LIFE) Capital Expenditures (2025 - 2026) Analysis & Trends
Ethos Technologies has reported Capital Expenditures for 2 years, with the latest figure at $325000.0 in Q2 2026.
- On a quarterly basis, Capital Expenditures rose 8.33% year-over-year to $325000.0 in Q2 2026; TTM through Jun 2026 was $1.3 million, a N/A change from a year earlier, with the FY2025 full-year figure at $1.5 million, up 92.14% from the prior year.
- Capital Expenditures was $325000.0 for Q2 2026 at Ethos Technologies, down from $353000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $353000.0 in Q1 2026, with the low at $278000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 6.99 Bn | 6.60 Bn | 183.95 Mn | 1.73 Mn |
| 2 | Hims & Hers Health | 6.38 Bn | 5.54 Bn | 480.80 Mn | 25.93 Mn |
| 3 | Ethos Technologies | 2.47 Bn | 2.30 Bn | 185.54 Mn | 325,000.00 |
| 4 | Omada Health | 1.28 Bn | 1.06 Bn | 63.79 Mn | 1.52 Mn |
| 5 | Teladoc Health | 1.11 Bn | 330.82 Mn | 416.09 Mn | 27.99 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | 3.13 Mn |
| 7 | Akso Health | 208.18 Mn | 208.01 Mn | - | - |
| 8 | LifeMD | 145.04 Mn | 145.04 Mn | - | - |
| 9 | eHealth | 29.43 Mn | -71.61 Mn | - | 2.20 Mn |
| 10 | Mangoceuticals | 6.82 Mn | 6.58 Mn | 44,215.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 325,000.00 |
| Mar 31, 2026 | 353,000.00 |
| Jun 30, 2025 | 300,000.00 |
| Mar 31, 2025 | 278,000.00 |